REP1 deficiency causes systemic dysfunction of lipid metabolism and oxidative stress in choroideremia

Cunha, Dulce Lima, Richardson, Rose, Tracey-White, Dhani, Abbouda, Alessandro, Mitsios, Andreas, Horneffer-van der Sluis, Verena, Takis, Panteleimon, Owen, Nicholas, Skinner, Jane, Welch, Ailsa A and Moosajee, Mariya (2021) REP1 deficiency causes systemic dysfunction of lipid metabolism and oxidative stress in choroideremia. JCI Insight, 6 (9). ISSN 2379-3708

[thumbnail of lima_cunha_welch_REP1_choroideremia_2021]
Preview
PDF (lima_cunha_welch_REP1_choroideremia_2021) - Published Version
Available under License Creative Commons Attribution.

Download (1MB) | Preview

Abstract

Choroideremia (CHM) is an X-linked recessive chorioretinal dystrophy caused by mutations in CHM, encoding for Rab escort protein 1 (REP1). Loss of functional REP1 leads to the accumulation of unprenylated Rab proteins and defective intracellular protein trafficking, the putative cause for photoreceptor, retinal pigment epithelium (RPE), and choroidal degeneration. CHM is ubiquitously expressed, but adequate prenylation is considered to be achieved, outside the retina, through the isoform REP2. Recently, the possibility of systemic features in CHM has been debated; therefore, in this study, whole metabolomic analysis of plasma samples from 25 CHM patients versus age- and sex-matched controls was performed. Results showed plasma alterations in oxidative stress-related metabolites, coupled with alterations in tryptophan metabolism, leading to significantly raised serotonin levels. Lipid metabolism was disrupted with decreased branched fatty acids and acylcarnitines, suggestive of dysfunctional lipid oxidation, as well as imbalances of several sphingolipids and glycerophospholipids. Targeted lipidomics of the chmru848 zebrafish provided further evidence for dysfunction, with the use of fenofibrate over simvastatin circumventing the prenylation pathway to improve the lipid profile and increase survival. This study provides strong evidence for systemic manifestations of CHM and proposes potentially novel pathomechanisms and targets for therapeutic consideration.

Item Type: Article
Uncontrolled Keywords: medicine(all) ,/dk/atira/pure/subjectarea/asjc/2700
Faculty \ School: Faculty of Medicine and Health Sciences > Norwich Medical School
UEA Research Groups: Faculty of Science > Research Groups > Norwich Epidemiology Centre
Faculty of Medicine and Health Sciences > Research Groups > Norwich Epidemiology Centre
Faculty of Medicine and Health Sciences > Research Centres > Population Health
Related URLs:
Depositing User: LivePure Connector
Date Deposited: 10 Jun 2021 00:08
Last Modified: 19 Oct 2023 02:59
URI: https://ueaeprints.uea.ac.uk/id/eprint/80246
DOI: 10.1172/jci.insight.146934

Downloads

Downloads per month over past year

Actions (login required)

View Item View Item